About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Acta Oncológica
›
Top Articles
Acta Oncológica
Hematology
,
Radiology
,
Oncology
3.2
(top 5%)
Impact Factor
3.6
(top 5%)
extended IF
117
(top 3%)
H-Index
3.6K
authors
6.3K
papers
129.5K
citations
7.1K
citing journals
55.4K
citing authors
Most Cited Articles of Acta Oncológica
Title
Year
Citations
The hazard of accelerated tumor clonogen repopulation during radiotherapy
1988
1.3K
The completeness of the Swedish Cancer Register: a sample survey for year 1998
2009
782
Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients
1995
704
Data quality and quality control of a population-based cancer registry. Experience in Finland
1994
553
Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects
1994
464
Occupation and cancer - follow-up of 15 million people in five Nordic countries
2009
433
Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study
2006
377
NORDCAN--a Nordic tool for cancer information, planning, quality control and research
2010
343
Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group
1994
325
Phase II study on stereotactic body radiotherapy of colorectal metastases
2006
320
Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients
1992
300
Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies
2015
297
Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability
2013
284
Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population
2000
270
The radiobiology of prostate cancer including new aspects of fractionated radiotherapy
2005
268
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis
2014
261
The spontaneous regression of cancer. A review of cases from 1900 to 1987
1990
257
Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis
2009
251
Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters
2010
244
Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994
2002
243
The pathology of ionizing radiation as defined by morphologic patterns
2005
229
Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx
1988
225
Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies
1988
222
The nation-wide Swedish family-cancer database--updated structure and familial rates
2001
220
EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma
1998
220
previous
2004
2005
2006
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.